» Articles » PMID: 22210181

Inflammation and Immune Surveillance in Cancer

Overview
Specialty Oncology
Date 2012 Jan 3
PMID 22210181
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic inflammation is a risk factor for tumor development. However, understanding the effect of the immune system on tumor development has only been significantly advanced over the past two decades. We now appreciate that the immune system, in addition to tumor-suppressive function by eliminating nascent transformed tumor cells, can also exert selection pressure on tumor cells and facilitate tumor growth by providing a favorable tumor microenvironment. Yet, the distinctions between tumor-promoting inflammation and tumor-suppressive immunity are still not clear due to the dual role of some cytokines and other molecules in the immune system. The danger signal hypothesis has shaped our view of the role of immunity in cancer development, but still little is known about the exact role of danger signal receptors in cancer progression. In this review, we introduce the processes of cancer immunoediting and inflammation-induced cancer and discuss what is currently known about the role of danger signal receptors in cancer development and progression.

Citing Articles

The PACT Network: PRL, ARL, CNNM, and TRPM Proteins in Magnesium Transport and Disease.

Jolly J, Blackburn J Int J Mol Sci. 2025; 26(4).

PMID: 40003994 PMC: 11855589. DOI: 10.3390/ijms26041528.


IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer.

Oyende Y, Taus L, Fatatis A Cancers (Basel). 2025; 17(2).

PMID: 39858071 PMC: 11763358. DOI: 10.3390/cancers17020290.


Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survival.

Kachuri L, Guerra G, Nakase T, Wendt G, Hansen H, Molinaro A Nat Commun. 2025; 16(1):658.

PMID: 39809742 PMC: 11732991. DOI: 10.1038/s41467-025-55919-6.


Steering the course of CAR T cell therapy with lipid nanoparticles.

Khawar M, Afzal A, Si Y, Sun H J Nanobiotechnology. 2024; 22(1):380.

PMID: 38943167 PMC: 11212433. DOI: 10.1186/s12951-024-02630-1.


Recent Findings on Therapeutic Cancer Vaccines: An Updated Review.

Sheikhlary S, Lopez D, Moghimi S, Sun B Biomolecules. 2024; 14(4).

PMID: 38672519 PMC: 11048403. DOI: 10.3390/biom14040503.